PRA Health Sciences was selected to conduct a global program of studies that targeted 2,200+ patients with multiple sclerosis (MS). Although there were many challenges, the study team implemented a comprehensive risk-management plan that resulted in achieved recruitment goals and positioned the sponsor as a “Sponsor of Choice” in MS research.
Explore related content and topics
White Paper
Multi-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes
Conducting clinical trials in rare diseases and advancing research pipelines requires a collaborative, multi-stakeholder approach. This process…
Blog
Celebrating World Creativity and Innovation Day with Lucy Morrow
Being creative is a part of being human. For World Creativity and Innovation Day, learn about our own Lucy Morrow and her passion for pop culture art…
Fact Sheet
Vaccine Solutions
PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will…